Skip to main content

Research Repository

Advanced Search

Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer

Abdel-Fatah, T. M.; Ball, G.; Lee, A. H. S.; Pinder, S.; MacMilan, R. D.; Cornford, E.; Moseley, P. M.; Silverman, R.; Price, J.; Latham, B.; Palmer, D.; Chan, A.; Ellis, I. O.; Chan, S. Y. T.

Authors

T. M. Abdel-Fatah

G. Ball

A. H. S. Lee

S. Pinder

R. D. MacMilan

E. Cornford

P. M. Moseley

R. Silverman

J. Price

B. Latham

D. Palmer

A. Chan

S. Y. T. Chan



Citation

Abdel-Fatah, T. M., Ball, G., Lee, A. H. S., Pinder, S., MacMilan, R. D., Cornford, E., …Chan, S. Y. T. (2015). Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer. Clinical Cancer Research, 21(5), 1052-1062. https://doi.org/10.1158/1078-0432.ccr-14-0685

Journal Article Type Article
Acceptance Date Dec 1, 2014
Online Publication Date Dec 17, 2014
Publication Date Mar 1, 2015
Deposit Date Dec 5, 2018
Journal Clinical Cancer Research
Print ISSN 1078-0432
Electronic ISSN 1557-3265
Publisher American Association for Cancer Research
Peer Reviewed Peer Reviewed
Volume 21
Issue 5
Pages 1052-1062
DOI https://doi.org/10.1158/1078-0432.ccr-14-0685
Public URL https://nottingham-repository.worktribe.com/output/1371392
Publisher URL http://clincancerres.aacrjournals.org/content/21/5/1052